Specifically, data from different laboratories evidence that CXCR4 exerts its tumor-promoting effects to accelerate cancer cell proliferation, migration and invasion in ovarian cancer [42], glioblastoma [41], colorectal cancer [40], and prostate cancer [39]. Here, CXCR4 is linked to prostate carcinoma.